CLARIVATE PLC
NYSE:CLVT

Watchlist Manager
CLARIVATE PLC Logo
CLARIVATE PLC
NYSE:CLVT
Watchlist
Price: 3.62 USD 3.43% Market Closed
Market Cap: 2.5B USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one CLVT stock under the Base Case scenario is 11.57 USD. Compared to the current market price of 3.62 USD, CLARIVATE PLC is Undervalued by 69%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CLVT Relative Value
Base Case
11.57 USD
Undervaluation 69%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1
P/S
P/S
Price to Sales
1
vs History
98
vs Industry
47
Median 3Y
2.1
Median 5Y
2.9
Industry
1.3
Forward
1
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
27
Median 3Y
-3.5
Median 5Y
-6.3
Industry
18.7
Forward
5.6
More Details
3.9
P/OCF
P/OCF
Price to OCF
3.9
vs History
98
vs Industry
67
Median 3Y
8.1
Median 5Y
18
Industry
12.5
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
30
Median 3Y
-11.7
Median 5Y
4.6
Industry
17
More Details
0.5
P/B
P/B
Price to Book Value
0.5
vs History
98
vs Industry
86
Median 3Y
0.8
Median 5Y
1
Industry
2.3
More Details
2.6
EV/S
EV/S
Enterprise Value to Sales
2.6
vs History
98
vs Industry
24
Median 3Y
3.8
Median 5Y
4.7
Industry
1.3
Forward
2.8
More Details
4
EV/GP
EV/GP
Enterprise Value to Gross Profit
4
vs History
98
vs Industry
34
Median 3Y
5.9
Median 5Y
7.3
Industry
3.1
More Details
6.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
6.9
vs History
98
vs Industry
48
Median 3Y
9.1
Median 5Y
12.8
Industry
9.8
Forward
6.8
More Details
26.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
26.6
vs History
84
vs Industry
14
Median 3Y
34.3
Median 5Y
49
Industry
12.9
Forward
33.4
More Details
10.4
EV/OCF
EV/OCF
Enterprise Value to OCF
10.4
vs History
98
vs Industry
40
Median 3Y
14.2
Median 5Y
30.7
Industry
11.8
More Details
20.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
20.6
vs History
88
vs Industry
19
Median 3Y
23.5
Median 5Y
48.7
Industry
13.9
More Details
0.6
EV/IC
EV/IC
Enterprise Value to IC
0.6
vs History
98
vs Industry
75
Median 3Y
0.8
Median 5Y
0.9
Industry
1.7
More Details

Multiples Across Competitors

CLVT Competitors Multiples
CLARIVATE PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
CLARIVATE PLC
NYSE:CLVT
2.5B USD 1 -3.7 6.9 26.6
UK
Relx PLC
LSE:REL
74.3B GBP 7.9 38.4 22 28.1
CA
Thomson Reuters Corp
TSX:TRI
113.3B CAD 11.3 37.1 27.8 38.7
IE
Experian PLC
LSE:EXPN
33.2B GBP 6.1 37.4 189.6 266.9
UK
IHS Markit Ltd
F:0M3
37.9B EUR 9.3 35.7 26.4 39.5
NL
Wolters Kluwer NV
AEX:WKL
35.8B EUR 6.1 33.2 20.1 26.7
US
Verisk Analytics Inc
NASDAQ:VRSK
40.2B USD 13.9 41.9 27.2 33.8
US
CoStar Group Inc
NASDAQ:CSGP
33.9B USD 12.4 244.5 199.4 6 433.1
US
Equifax Inc
NYSE:EFX
31.9B USD 5.6 52 20.6 34.2
US
Leidos Holdings Inc
NYSE:LDOS
19.1B USD 1.1 15.2 10.6 12.2
CH
SGS SA
SIX:SGSN
15.2B CHF 2.2 26.1 12.4 18.8
P/E Multiple
Earnings Growth PEG
UK
CLARIVATE PLC
NYSE:CLVT
Average P/E: 56.2
Negative Multiple: -3.7 		N/A N/A
UK
Relx PLC
LSE:REL
38.4
16%
2.4
CA
Thomson Reuters Corp
TSX:TRI
37.1
1%
37.1
IE
Experian PLC
LSE:EXPN
37.4
15%
2.5
UK
I
IHS Markit Ltd
F:0M3
35.7
N/A N/A
NL
Wolters Kluwer NV
AEX:WKL
33.2
10%
3.3
US
Verisk Analytics Inc
NASDAQ:VRSK
41.9
10%
4.2
US
CoStar Group Inc
NASDAQ:CSGP
244.5
79%
3.1
US
Equifax Inc
NYSE:EFX
52
36%
1.4
US
Leidos Holdings Inc
NYSE:LDOS
15.2
9%
1.7
CH
SGS SA
SIX:SGSN
26.1
15%
1.7
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
UK
CLARIVATE PLC
NYSE:CLVT
Average EV/EBITDA: 51.2
6.9
2%
3.4
UK
Relx PLC
LSE:REL
22
10%
2.2
CA
Thomson Reuters Corp
TSX:TRI
27.8
7%
4
IE
Experian PLC
LSE:EXPN
189.6
10%
19
UK
I
IHS Markit Ltd
F:0M3
26.4
N/A N/A
NL
Wolters Kluwer NV
AEX:WKL
20.1
7%
2.9
US
Verisk Analytics Inc
NASDAQ:VRSK
27.2
9%
3
US
CoStar Group Inc
NASDAQ:CSGP
199.4
88%
2.3
US
Equifax Inc
NYSE:EFX
20.6
16%
1.3
US
Leidos Holdings Inc
NYSE:LDOS
10.6
5%
2.1
CH
SGS SA
SIX:SGSN
12.4
11%
1.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
UK
CLARIVATE PLC
NYSE:CLVT
Average EV/EBIT: 632.6
26.6
27%
1
UK
Relx PLC
LSE:REL
28.1
13%
2.2
CA
Thomson Reuters Corp
TSX:TRI
38.7
10%
3.9
IE
Experian PLC
LSE:EXPN
266.9
14%
19.1
UK
I
IHS Markit Ltd
F:0M3
39.5
N/A N/A
NL
Wolters Kluwer NV
AEX:WKL
26.7
9%
3
US
Verisk Analytics Inc
NASDAQ:VRSK
33.8
10%
3.4
US
CoStar Group Inc
NASDAQ:CSGP
6 433.1
478%
13.5
US
Equifax Inc
NYSE:EFX
34.2
25%
1.4
US
Leidos Holdings Inc
NYSE:LDOS
12.2
6%
2
CH
SGS SA
SIX:SGSN
18.8
14%
1.3

See Also

Summary
CLVT intrinsic value, competitors valuation, and company profile.
DCF Valuation
CLVT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CLVT stock valuation using valuation multiples.
Wall Street Estimates
CLVT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CLVT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 249,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.